Evidence map›Paper›PMID 34746884›Full record

ArticleJTO clinical and research reports2021

Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations.

Giuseppe Pelosi, Matteo Bulloni, Martina Vescio, Silvia Uccella, Fabien Forest, Giorgia Leone, Massimo Barberis, Daoud Rahal, Paola Bossi, Giovanna Finzi and 11 more

Open access · goldAbstract read
In one paragraph

Article in JTO clinical and research reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 2 countries.

Giuseppe PelosiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Matteo BulloniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Martina VescioDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Silvia UccellaPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Fabien ForestDepartment of Pathology, University Hospital Center (CHU), North Hospital, Saint Etienne, France.
Giorgia LeonePathology Service, Humanitas Istituto Clinico Catanese, Catania, Italy.
Massimo BarberisHistopathology and Molecular Diagnostics Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS) European Institute of Oncology, Milan, Italy.
Daoud RahalDepartment of Pathology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS), Milan, Italy.
Paola BossiDepartment of Pathology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS), Milan, Italy.
Giovanna FinziPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Deborah MarchioriPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Marco De LucaPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Fausto SessaPathology Unit, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Sergio HarariDepartment of Medical Sciences and Community Health, University of Milan, Milan, Italy.
Manuela SpinelliCellular Pathology Department, Worcester Royal Hospital, Worcester, United Kingdom.
Patrizia ViolaCellular Pathology Department, Hammersmith Hospital, London, United Kingdom.
Paolo MacrìDivision of Oncologic Thoracic Surgery, Humanitas Istituto Clinico Catanese, Catania, Italy.
Stefania MariaDivision of Oncologic Thoracic Surgery, Humanitas Istituto Clinico Catanese, Catania, Italy.
Antonio RizzoPathology Service, Humanitas Istituto Clinico Catanese, Catania, Italy.
Antonio PiconeDepartment of Oncology, Humanitas Istituto Clinico Catanese, Catania, Italy.
Linda PattiniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
University of Insubria · ITPolitecnico di Milano · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Milan · ITEuropean Institute of Oncology · ITHammersmith Hospital · GBWorcestershire Royal Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Double occurrence of TTF1 and ΔNp63/p40 (henceforth, p40) within the same individual cells is exceedingly rare in lung cancer. Little is known on their biological and clinical implications. Methods: Two index cases immunoreactive for both p40 and TTF1 and nine tumors selected from The Cancer Genome Atlas (TCGA) according to the mRNA levels of the two relevant genes entered the study. Results: The two index cases were peripherally located, poorly differentiated, and behaviorally unfavorable carcinomas, which shared widespread p40 and TTF1 decoration within the same individual tumor cells. They also retained SMARCA2 and SMARCA4 expression, while variably stained for p53, cytokeratin 5, and programmed death-ligand 1. A subset of basal cells p40+/TTF1+ could be found in normal distal airways. Biphenotypic glandular and squamous differentiation was unveiled by electron microscopy, along with Conclusions: Double p40+/TTF1+ lung carcinomas are aggressive and likely underrecognized non-small cell carcinomas, whose origin could reside in double-positive distal airway stem-like basal cells through either de novo-basal-like or differentiating cell mechanisms according to a model of epithelial renewal.

Indexed as

LungNon–small cell carcinomaPrognosisTTF-1ΔNp63/p40

Identifiers

PMID34746884
PMCPMC8551500
OpenAlexW3197629651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.